Qing Bile Therapeutics Inc.

Qing Bile Therapeutics Inc.

Qing Bile Therapeutics Inc. is created in 2015 to develop and commercialize effective pharmaceuticals based on its unique proprietary Tetrahydroxylated Bile Acid (THBA) Platform to treat bile acid imbalance metabolic diseases. There is tremendous untapped potential to intervene, to produce therapeutics for a host of unmet medical needs.

Area of focus: 
Cardiovascular and Metabolism
Commencement date: 
06/01/2017

Contact

  • Charles Chee

    Director, Corporate Development and Administration

Share